Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification
Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS Device
Brixton Metals Announces Upsize of Previously Announced Non-Brokered Private Placement to $8 Million and Closing of Second Tranche
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
